Skip to main content
An official website of the United States government

PEG-interleukin-2

A complex of polyethylene glycol conjugated with human recombinant cytokine interleukin-2 (IL-2) with antineoplastic activity. PEG-interleukin-2 induces natural killer (NK) cell activity and the production of interferon-gamma (IFN-gamma), and enhances T cell-mediated cytotoxicity. Pegylation of IL-2 protects the cytokine from degradation.
Check for active clinical trials using this agentView this agent in the NCI Thesaurus
Synonym:polyethylene glycol-modified recombinant interleukin-2
Abbreviation:PEG-IL-2
IND number:3646
Search NCI's Drug Dictionary
Please enter up to 30 characters for your search